Walleye Capital LLC Codexis, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.75 $385,108 - $962,771	-256,739 Reduced 94.85%	13,952 $26,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $102,201 - $204,865	-46,245 Reduced 14.59%	270,691 $757,000
Q1 2023 May 15, 2023	SELL	$3.81 - $6.76 $55,938 - $99,250	-14,682 Reduced 4.43%	316,936 $1.31 Million
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $17,368 - $27,886	4,077 Added 1.24%	331,618 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $1.91 Million - $4.06 Million	315,746 Added 2676.95%	327,541 $1.99 Million
Q2 2022 Aug 08, 2022	BUY	$8.35 - $21.89 $98,488 - $258,192	11,795 New	11,795 $123,000
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $146,077 - $274,853	-8,608 Closed	0 $0
Q4 2021 Mar 03, 2022	SELL	$25.61 - $41.78 $99,264 - $161,939	-3,876 Reduced 31.05%	8,608 $269,000
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $245,310 - $349,427	12,484 New	12,484 $290,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.